StockData

Fractyl Health vs PAVmed

GUTS and PAVM side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GUTS and PAVM compare

Fractyl Health is the larger company, worth 13 times as much as PAVmed ($154M against $12.1M).

PAVmed scores higher on the StockData Score (6 against 1 for Fractyl Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGUTSPAVM
Size and price
Market cap$154M$12.1M
Share price$0.965$1.51
Change, 1 year−93.6%−84.3%
Change, 5 years–−99.9%
Beta (5Y)2.531.47
Employees1003
StockData Score
Total score16 (better)
Valuation score01 (better)
Growth score00
Performance score01 (better)
Health score14 (better)
Dividend score00
Valuation
P/S–108×
P/B–0.3×
FCF yield–−64.5%
Growth
Revenue growth (TTM)–−89.0%
Net income growth (TTM)–−117%
Profitability
Gross margin–−221%
Operating margin–−23843%
Net margin–−10795%
FCF margin–−6948%
Return on equity–−33.3%
Return on invested capital–−65.1%
Financial health
Debt / equity–0.00
Interest coverage–−3338.0×
Current ratio3.15 (better)1.19
Altman Z-score−11.64−11.03 (better)
Piotroski F-score34 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions4.3%11.7%
Held by insiders5.5%23.5%
Insider net buying, 12 months$187K–
Short interest, % of float0.39%0.21%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.